Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in Generalized Myasthenia Gravis
NCT01480596Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2013
- Primary completion
- Aug 2015
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of belimumab in myasthenia gravis (MG), sponsored by GSK. Started Apr 2013; status: completed.
02
Drugs
belimumab
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on NCT01480596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480596.